Jump to main content
Jump to site search

Issue 43, 2007
Previous Article Next Article

Some uses of transition metal complexes as anti-cancer and anti-HIV agents

Author affiliations

Abstract

The success of the clinical uses of cisplatin, cis-[PtII(NH3)2Cl2], has stimulated considerable interest in using other metal complexes as new therapeutic agents. This perspective describes our recent work on several classes of gold(III), platinum(II), ruthenium(II, III, IV), iron(II) and vanadium(IV) complexes for anti-cancer and anti-HIV treatments.

Graphical abstract: Some uses of transition metal complexes as anti-cancer and anti-HIV agents

Back to tab navigation

Article information


Submitted
03 Apr 2007
Accepted
04 Jun 2007
First published
18 Sep 2007

Dalton Trans., 2007, 4884-4892
Article type
Perspective

Some uses of transition metal complexes as anti-cancer and anti-HIV agents

R. Wai-Yin Sun, D. Ma, E. L. Wong and C. Che, Dalton Trans., 2007, 4884
DOI: 10.1039/B705079H

Social activity

Search articles by author

Spotlight

Advertisements